Alere, a part of Abbott, specializes in rapid point-of-care diagnostics, offering a range of innovative testing solutions designed to enhance patient care. Their flagship products include the i-STAT System, which allows healthcare professionals to perform diagnostic tests and receive results in real-time, directly at the point of care. The i-STAT CHEM8+ cartridge enables quick assessments of various blood chemistries and hematological parameters within minutes, while the Afinion™ 2 analyzer provides multi-assay capabilities for near-patient testing without the need for laboratory processing. Additionally, the Cholestech LDX™ Analyzer delivers lab-accurate lipid profiles and glucose levels in just five minutes, empowering clinicians to make informed decisions during patient visits.

In response to the ongoing healthcare challenges, Alere has developed specific tests such as the ID NOW™ COVID-19 assay, which provides rapid molecular results for SARS-CoV-2 detection in as little as 6-12 minutes. Their BinaxNOW COVID-19 Antigen Self-Test is recognized as a leading self-test option in the U.S., further emphasizing their commitment to accessible and timely diagnostics. Alere's technologies are designed to streamline the testing process, improve patient outcomes, and support healthcare professionals with valuable insights and tools for effective decision-making at the point of care.

United States

Alere is now Abbott! Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries.

Alere (Abbott)

Company Details